Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Halabi

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Gut|June 1, 1991
Negative chronotropic effects of nizatidineA Halabi, W Kirch
Scandinavian Journal of Gastroenterology|September 1, 1992
Cardiovascular effects of omeprazole and famotidineA Halabi, W Kirch
Journal of the American Chemical Society|April 5, 2023
Light-Deactivated Fluorescent Probes (FLASH-Off) for Multiplexed ImagingElias A Halabi, Ralph Weissleder
Clinical Pharmacology and Therapeutics|September 1, 1990
Hemodynamic effects of different H2-receptor antagonistsH Hinrichsen, A Halabi, W Kirch
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1992
Arachidonic acid channelling in the phospholipid fractions and subcellular compartments of cultured myocardial cellsA Halabi, N Nachas, A Pinson
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1992
Mechanical injury increases eicosanoid production in cultured cardiomyocytesA Pinson, A Halabi, E Shohami
Journal of Clinical Pharmacology|February 1, 1995
Clinical aspects of cardiovascular effects of H2-receptor antagonistsH Hinrichsen, A Halabi, W Kirch
Clinical Pharmacology and Therapeutics|March 1, 1992
Hemodynamic effects of quinidine and famotidine in patients with congestive heart failureW Kirch, A Halabi, H Hinrichsen
The Clinical Investigator|February 1, 1992
Haemodynamic effects of roxatidine, an H2-receptor antagonistA Halabi, A Nokhodian, W Kirch
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1993
Bunazosin in patients with impaired hepatic or renal functionA Halabi, A Nokhodian, W Kirch
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Gut|June 1, 1991
Negative chronotropic effects of nizatidineA Halabi, W Kirch
Scandinavian Journal of Gastroenterology|September 1, 1992
Cardiovascular effects of omeprazole and famotidineA Halabi, W Kirch
Journal of the American Chemical Society|April 5, 2023
Light-Deactivated Fluorescent Probes (FLASH-Off) for Multiplexed ImagingElias A Halabi, Ralph Weissleder
Clinical Pharmacology and Therapeutics|September 1, 1990
Hemodynamic effects of different H2-receptor antagonistsH Hinrichsen, A Halabi, W Kirch
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1992
Arachidonic acid channelling in the phospholipid fractions and subcellular compartments of cultured myocardial cellsA Halabi, N Nachas, A Pinson
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1992
Mechanical injury increases eicosanoid production in cultured cardiomyocytesA Pinson, A Halabi, E Shohami
Journal of Clinical Pharmacology|February 1, 1995
Clinical aspects of cardiovascular effects of H2-receptor antagonistsH Hinrichsen, A Halabi, W Kirch
Clinical Pharmacology and Therapeutics|March 1, 1992
Hemodynamic effects of quinidine and famotidine in patients with congestive heart failureW Kirch, A Halabi, H Hinrichsen
The Clinical Investigator|February 1, 1992
Haemodynamic effects of roxatidine, an H2-receptor antagonistA Halabi, A Nokhodian, W Kirch
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1993
Bunazosin in patients with impaired hepatic or renal functionA Halabi, A Nokhodian, W Kirch
Pageof 7